TORONTO--(BUSINESS WIRE)--Mednow Inc. (“Mednow” or the “Company”) (TSXV: MNOW) (OTCQX: MDNWF) announced today the launch of its enhanced Virtual Diabetes Management program, an end-to-end digital ...

DexCom, Inc. DXCM recently announced that people living with type 1 and type 2 diabetes age two and above on multiple daily injections of insulin (three or above) or who are dependent on an insulin ...

Dexcom G6 was the first Continuous Glucose Monitoring (CGM) System to be officially listed by the NIHB Drug Benefit program. BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), ...

Huons announced on the 29th that it has decided to expand the free support of transmitters for the continuous glucose monitor (CGM) 'Dexcom G6' for diabetes patients. The transmitter is a device that ...

Dexcom G6 gives people with diabetes the power to manage their condition without fingersticks* or scanning Proven to improve glycemic control and can reduce the risk of costly long-term ...

DexCom, Inc. DXCM recently announced that the new Dexcom ONE Continuous Glucose Monitoring System (CGM) would be introduced in the U.K. in May. This new system is an easy-to-use real-time CGM (rt-CGM) ...

The digital healthcare business of South Korean internet company Kakao Corporation has entered into a collaboration agreement with Dexcom to set up a global digital diabetes management service.

The next generation RxFood app, featuring Dexcom CGM glucose data integration, is now available to health care program stakeholders across Canada including clinics, hospitals, health authorities, ...

After months of international availability, the Dexcom G7 constant glucose monitor received its FDA clearance to distribute in the US. Ahead of the wide rollout, we got to go hands-on with a demo ...